1999Zhongguo yaofangRequires access

Pharmacokinetics and Bioavailability of Captopril in Healthy Volunteers

Yang Wanxin

Open publisher page 0 citations

Abstract

OBJECTIVES:To compare the bioavailability and pharmacokinetics of captopril between products of two factories.METHODS:An open randomized crossover study was carried out in 9 healthy volunteers who received a single oral dose of 30mg captopril,taking β bromophenacyl bromide as ramification.Drug concentrations in plasma were assayed by HPLC method.RESULTS:The concentration time course after medication conformed to a 2 compartment open model with a first order absorption.The pharmacokinetic parameters of Captopril of A and B medicine factories were:Tmax(0.94±0.13)h,(1.00±0.15)h,Cmax(92.03±27.36)ng/ml,(74.67±19.29)ng/ml,AUC(252.78±68.14)ng/(h·L),(251.19±50.13)ng/(h·L)respectively.CONCLUSIONS:The results showed that the bioavailability for the testing tablet was 99.37%,the two formulations were bioequivalent.

About this research paper

What this paper is about

OBJECTIVES:To compare the bioavailability and pharmacokinetics of captopril between products of two factories.METHODS:An open randomized crossover study was carried out in 9 healthy volunteers who received a single oral dose of 30mg captopril,taking β bromophenacyl bromide as ramification.Drug concentrations in plasma were assayed by HPLC method.RESULTS:The concentration time course after medication conformed to a 2 compartment open model with a first order absorption.The pharmacokinetic parameters of Captopril of A and B medicine factories were:Tmax(0.94±0.13)h,(1.00±0.15)h,Cmax(92.03±27.36)ng/ml,(74.67±19.29)ng/ml,AUC(252.78±68.14)ng/(h·L),(251.19±50.13)ng/(h·L)respectively.CONCLUSIONS:The results showed that the bioavailability for the testing tablet was 99.37%,the two formulations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVES:To compare the bioavailability and pharmacokinetics of captopril between products of two factories.METHODS:An open randomized crossover study was carried out in 9 healthy volunteers who received a single oral dose of 30mg captopril,taking β bromophenacyl bromide as ramification.Drug concentrations in plasma were assayed by HPLC method.RESULTS:The concentration time course after medication conformed to a 2 compartment open model with a first order absorption.The pharmacokinetic parameters of Captopril of A and B medicine factories were:Tmax(0.94±0.13)h,(1.00±0.15)h,Cmax(92.03±27.36)ng/ml,(74.67±19.29)ng/ml,AUC(252.78±68.14)ng/(h·L),(251.19±50.13)ng/(h·L)respectively.CONCLUSIONS:The results showed that the bioavailability for the testing tablet was 99.37%,the two formulations were bioequivalent.

Key concepts: Bioavailability, Pharmacokinetics, Bioequivalence, Captopril, Cmax, Pharmacology, Crossover study, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacokinetics and Bioavailability of Captopril in Healthy Volunteers — Research Paper | ScholarLens